Filing Flows › Ginkgo Bioworks Holdings (DNA) › R&D spending
Ginkgo Bioworks Holdings (DNA) R&D spending by quarter
Ginkgo Bioworks Holdings' R&D spending was $46.2M in Q2 2026 (second quarter 2026), -7% from Q1 2026. Over the last 7 quarters it ranged from $46.2M (Q2 2026) to $76.4M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $46.2M | -7% | -13% |
| Q1 2026 | $49.9M | -0.4% | -30% |
| Q4 2025 | $50.1M | -28% | -34% |
| Q3 2025 | $69.4M | +30% | — |
| Q2 2025 | $53.4M | -25% | — |
| Q1 2025 | $70.9M | -7% | — |
| Q4 2024 | $76.4M | — | — |
Q2 2026 at a glance
Ginkgo Bioworks Holdings, Q2 2026: revenue $20.2M (-48% year over year), operating margin -290.5%, net loss $46.7M, operating cash flow −$44.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Ginkgo Bioworks Holdings' R&D spending?
Ginkgo Bioworks Holdings' R&D spending was $46.2M in Q2 2026 (second quarter 2026), -7% from Q1 2026.
How has Ginkgo Bioworks Holdings' R&D spending changed?
Over the last 7 quarters it ranged from $46.2M (Q2 2026) to $76.4M (Q4 2024).
Q2 2026 results → · How Ginkgo Bioworks Holdings makes money →